Previous Close | 0.5900 |
Open | 0.5311 |
Bid | 0.3778 x 200 |
Ask | 0.6501 x 200 |
Day's Range | 0.4966 - 0.5489 |
52 Week Range | 0.4960 - 21.8000 |
Volume | |
Avg. Volume | 655,583 |
Market Cap | 744,310 |
Beta (5Y Monthly) | 2.83 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
SAN FRANCISCO, May 09, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the pricing of its public offering of an aggregate of 4,710,000 shares of its common stock, Series A warrants to purchase up to 4,710,000 shares of common stock and Series B warrants to purchase up to 7,065,000 shares of common stock, at a public offering price of $0.85 per share and accompanying warrants. The Series A wa
SAN FRANCISCO, May 08, 2024--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today the final results of their pilot research study with The Feinstein Institutes for Medical Research at Northwell Health. Through this collaboration, Tivic Health has confirmed the effectiveness of its patent-pending non-invasive cervical vagus nerve stimulation (ncVNS) approach, which induces responses in the autono
SAN FRANCISCO, March 25, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its financial results for the year ending December 31, 2023.